NNK induces proliferation and inhibits apoptosis in NSCLC cells in vivo by downregulating miR-124 expression, leading to the activation of Akt, thereby enhancing NSCLC progression [90]. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.